🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,589 results for “Pharma” Clear

  1. Bexarotene

    LIGAND PHARMACEUTICALS INC

    Sarcoma, Kaposi

    phase 2 small molecule completed

    1 trial

  2. Bexarotene

    LIGAND PHARMACEUTICALS INC

    Lung Cancer

    phase 2 small molecule completed

    1 trial

  3. Bexarotene (targretin)

    LIGAND PHARMACEUTICALS INC

    Carcinoma, Non-small-cell Lung

    phase 2 small molecule terminated

    1 trial

  4. Bexarotene 1% gel

    LIGAND PHARMACEUTICALS INC

    Parapsoriasis

    phase 2 small molecule terminated

    1 trial

  5. Bexarotene/NBUVB vs placebo NBUVB

    LIGAND PHARMACEUTICALS INC

    Psoriasis

    phase 2 small molecule completed

    1 trial

  6. Bexmarilimab

    Lacuna Pharma Pty Ltd

    Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  7. Bicarbonate de sodium

    Jazz Pharmaceuticals Ireland Limited

    Hematologic Disease

    phase 2 small molecule completed

    1 trial

  8. Bicifadine

    XTL BIOPHARMACEUTICALS LTD

    Diabetic Peripheral Neuropathy

    phase 2 small molecule active

    1 trial

  9. Bicifadine

    XTL BIOPHARMACEUTICALS LTD

    Chronic Peripheral Neuropathy Pain in Diabetics

    phase 2 small molecule terminated

    1 trial

  10. Bion 1301/FUB523

    Novartis Pharmaceuticals

    IgA nephropathy

    phase 2 small molecule active

    1 trial

  11. Bivamelagon

    Rhythm Pharmaceuticals Netherlands B.V.

    Hypothalamic Obesity

    phase 2 small molecule active

    1 trial

  12. Botulinum Toxin Type B (Myobloc)

    SUPERNUS PHARMACEUTICALS, INC.

    Drooling

    phase 2 mab completed

    1 trial

  13. Brexanolone

    SUPERNUS PHARMACEUTICALS, INC.

    Tinnitus

    phase 2 small molecule completed

    1 trial

  14. Brimo PS DDS®

    Allergan Pharmaceuticals International Limited

    Patients Who Participated in an Intravitreal Brimo PS DDS® Study

    phase 2 small molecule completed

    1 trial

  15. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    Cytomegalovirus Infection

    phase 2 small molecule completed

    1 trial

  16. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    Adenovirus

    phase 2 small molecule terminated

    2 trials

  17. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    Adenovirus Disease

    phase 2 small molecule completed

    1 trial

  18. Bronchodilator

    Teva Pharma GmbH

    Asthma

    phase 2 small molecule completed

    1 trial

  19. Budenofalk 4 mg Zäpfchen, placebo to test

    Dr. Falk Pharma GmbH

    Acute radiation proctitis symptoms in male patients aged 18 years or older with prostate carcinoma

    phase 2 small molecule active

    1 trial

  20. Budesonide

    LIGAND PHARMACEUTICALS INC

    Seasonal Allergic Rhinitis

    phase 2 small molecule completed

    1 trial

  21. Budesonide + Azelastine

    LIGAND PHARMACEUTICALS INC

    Seasonal Allergic Rhinitis

    phase 2 small molecule completed

    1 trial

  22. C16G2

    Armata Pharmaceuticals

    Dental Caries

    phase 2 small molecule completed

    3 trials

  23. C16G2 Gel

    Armata Pharmaceuticals

    Dental Caries

    phase 2 small molecule completed

    1 trial

  24. C16G2 Rinse

    Armata Pharmaceuticals

    Dental Caries

    phase 2 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources